Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.49 (
reverse transcriptase
)
31,746
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Lysyl hydroxylase 2
(
LH2
) is an endoplasmic reticulum (ER)-resident enzyme that catalyzes the hydroxylation of lysine residues in the telopeptides of fibrillar collagens. This is a critical modification to determine the fate of collagen cross-linking pathway that contributes to the stability of collagen fibrils. Studies have demonstrated that the aberrant
LH2
function causes various diseases including osteogenesis imperfecta, fibrosis, and cancer metastasis. However, surprisingly, a
LH2
-deficient animal model has not been reported. In the current study, to better understand the function of
LH2
, we generated
LH2
gene knockout mice by CRISPR/Cas9 technology.
LH2
deficiency was confirmed by genotyping polymerase chain reaction (PCR),
reverse transcriptase
-PCR, and immunohistochemical analyses. Homozygous
LH2
knockout (
LH2
-/-
) embryos failed to develop normally and died at early embryonic stage E10.5 with abnormal common ventricle in a heart, i.e., an insufficient wall, a thin ventricular wall, and loosely packed cells. In the
LH2
-/-
mice, the ER stress-responsive genes, ATF4 and CHOP were significantly up-regulated leading to increased levels of Bax and cleaved caspase-3. These data indicate that
LH2
plays an essential role in cardiac development through an ER stress-mediated apoptosis pathway.
...
PMID:Deficiency of lysyl hydroxylase 2 in mice causes systemic endoplasmic reticulum stress leading to early embryonic lethality. 3090 11